Nephros, Inc.
Nephros, Inc. (NEPH) Stock Overview
Explore Nephros, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
31M
P/E Ratio
32.00
EPS (TTM)
$0.14
ROE
0.12%
NEPH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Nephros, Inc. (NEPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 44.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.60.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.00 and a market capitalization of 31M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.